Enterprise 2支架治疗颅内动脉瘤的临床效果分析

Clinical Effect Analysis of Enterprise 2 Stent in Treatment of in Tracranial Aneurysms

目的 研究分析颅内动脉瘤在临床治疗环节中Enterprise 2支架的应用效果。方法 选取2021年6月—2022年12月在本院接受治疗的60例颅内动脉瘤患者展开试验分析,按照其治疗方式进行分组,将采用Enterprise 2支架展开治疗的患者作为观察组,选择保守治疗的患者30例作为对照组,对比两组患者治疗成功率以及临床症状改善情况。结果 经治疗,观察组患者治疗成功率显著高于对照组(P<0.05);经过6个月的随访发现,观察组患者临床症状改善情况显著优于对照组,差异具有统计学意义(P<0.05);观察组患者满意度显著优于对照组,差异具有统计学意义(P<0.05)。结论 Enterprise 2支架治疗操作比较简单,并且可以取得良好的治疗效果,相较于保守治疗而言,治疗效果显著,可以有效改善患者预后,值得在临床推广应用。

Objective To study and analyze application effect of Enterprise 2 stent in clinical treatment of intracranial aneurysms.Methods A trial analysis was conducted on 60 patients with intracranial aneurysms who received treatment in our hospital from June 2021 to December 2022.The treatment methods were analyzed according to their treatment methods.Patients who received Enterprise 2 stent treatment were selected as the observation group,while 30 patients who received conservative treatment were selected as the control group.Results The success rate of treatment and the improvement of clinical symptoms were compared between the two groups.After treatment,the success rate of treatment in the observation group was significantly higher than that in the control group(P< 0.05);After 6 months of follow-up,it was found from Table 2 that the improvement of clinical symptoms in the observation group was significantly better than that in the control group,with statistical significance(P<0.05);The satisfaction of patients in the observation group was significantly better than that in the control group,and the difference was statistically significant(P<0.05).Conclusion The Enterprise 2 stent treatment is relatively simple and can achieve good therapeutic effects.Compared with conservative treatment,the treatment effect is significant and can effectively improve patient prognosis.It is worth promoting and applying in clinical practice.